Lexicon Pharma (LXRX) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts LXRX Hot Sheet
Price: $2.35 --0%
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q4 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $21.4 million versus the consensus estimate of $11.97 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Madison Square Garden Sports Corp. (MSGS) Tops Q4 EPS by 62c
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
